BridgeMD
New treatment option for Cerebral Palsy (CP)
Official title Intensive Rehabilitation Program for Upper Limb in Children and Adolescents With Cerebral Palsy
ClinicalTrials.gov ID: NCT07285837
What this study is testing
- What it's testing
- Cerebral palsy is the most common motor disability in children. Individuals with CP often experience significant difficulties in the use of their upper limbs, which affects their autonomy and quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 17
You may be able to join if
- A clinical diagnosis of CP mentioned in the medical record
- Aged between 3 and 17 years inclusive (\<18 years)
- Global Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS) levels I to IV
- Ability to cooperate, understand and follow simple instructions
- Patient affiliated to the French social security system
You likely can't join if
- Presence of injuries incompatible with participation in the program, or pain rated \>3 on the Visual Analogue Scale (VAS)
- Presence of behavioral disorders
- History of botulinum toxin injections or surgical intervention within six months prior to study enrollment.
See the full eligibility criteria
- A clinical diagnosis of CP mentioned in the medical record
- Aged between 3 and 17 years inclusive (\<18 years)
- Global Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS) levels I to IV
- Ability to cooperate, understand and follow simple instructions
- Patient affiliated to the French social security system
- Voluntary patient whose parents have given their consent for their child to participate in the study.
- Presence of injuries incompatible with participation in the program, or pain rated \>3 on the Visual Analogue Scale (VAS)
- Presence of behavioral disorders
- History of botulinum toxin injections or surgical intervention within six months prior to study enrollment.
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Fargeau-Ponthierry, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Fargeau-Ponthierry, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.